SAINT PAUL, Minn., June 12, 2014 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the second quarter ended April 30, 2014.
Second Quarter Fiscal 2014 Highlights:
-- Net Income for the 2014 second quarter increased 22% to $308,000, or $0.07 per diluted share, compared to net income of $252,000, or $0.06 per diluted share in the 2013 second quarter;
Help employers find you! Check out all the jobs and post your resume.
